IBDEI03E ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4054,2)
 ;;=^123952
 ;;^UTILITY(U,$J,358.3,4055,0)
 ;;=332.0^^38^297^28
 ;;^UTILITY(U,$J,358.3,4055,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4055,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,4055,1,5,0)
 ;;=5^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,4055,2)
 ;;=Parkinson's Disease^304847
 ;;^UTILITY(U,$J,358.3,4056,0)
 ;;=250.60^^38^297^29
 ;;^UTILITY(U,$J,358.3,4056,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4056,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,4056,1,5,0)
 ;;=5^Peripheral Neuropathy, Diabetic
 ;;^UTILITY(U,$J,358.3,4056,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,4057,0)
 ;;=356.9^^38^297^31
 ;;^UTILITY(U,$J,358.3,4057,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4057,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,4057,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,4057,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,4058,0)
 ;;=780.2^^38^297^39
 ;;^UTILITY(U,$J,358.3,4058,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4058,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,4058,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,4058,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,4059,0)
 ;;=724.3^^38^297^35
 ;;^UTILITY(U,$J,358.3,4059,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4059,1,4,0)
 ;;=4^724.3
 ;;^UTILITY(U,$J,358.3,4059,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,4059,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,4060,0)
 ;;=780.39^^38^297^37
 ;;^UTILITY(U,$J,358.3,4060,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4060,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,4060,1,5,0)
 ;;=5^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,4060,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,4061,0)
 ;;=782.0^^38^297^27
 ;;^UTILITY(U,$J,358.3,4061,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4061,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,4061,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,4061,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,4062,0)
 ;;=435.9^^38^297^41
 ;;^UTILITY(U,$J,358.3,4062,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4062,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,4062,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,4062,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,4063,0)
 ;;=354.2^^38^297^43
 ;;^UTILITY(U,$J,358.3,4063,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4063,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,4063,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,4063,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,4064,0)
 ;;=729.1^^38^297^18
 ;;^UTILITY(U,$J,358.3,4064,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4064,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,4064,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,4064,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,4065,0)
 ;;=438.20^^38^297^7
 ;;^UTILITY(U,$J,358.3,4065,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4065,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,4065,1,5,0)
 ;;=5^CVA with Hemiplegia (late effect)
 ;;^UTILITY(U,$J,358.3,4065,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,4066,0)
 ;;=438.12^^38^297^6
 ;;^UTILITY(U,$J,358.3,4066,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4066,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,4066,1,5,0)
 ;;=5^CVA with Dysphasia (late effect)
 ;;^UTILITY(U,$J,358.3,4066,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,4067,0)
 ;;=356.8^^38^297^30
 ;;^UTILITY(U,$J,358.3,4067,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4067,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,4067,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,4067,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,4068,0)
 ;;=337.20^^38^297^33
 ;;^UTILITY(U,$J,358.3,4068,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4068,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,4068,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,4068,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,4069,0)
 ;;=294.8^^38^297^15
 ;;^UTILITY(U,$J,358.3,4069,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4069,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,4069,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,4069,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,4070,0)
 ;;=438.6^^38^297^4
 ;;^UTILITY(U,$J,358.3,4070,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4070,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,4070,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,4070,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,4071,0)
 ;;=438.7^^38^297^5
 ;;^UTILITY(U,$J,358.3,4071,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4071,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,4071,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,4071,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,4072,0)
 ;;=438.84^^38^297^3
 ;;^UTILITY(U,$J,358.3,4072,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4072,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,4072,1,5,0)
 ;;=5^CVA w/Ataxia (late effect)
 ;;^UTILITY(U,$J,358.3,4072,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,4073,0)
 ;;=434.91^^38^297^8
 ;;^UTILITY(U,$J,358.3,4073,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4073,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,4073,1,5,0)
 ;;=5^CVA, Acute Onset
 ;;^UTILITY(U,$J,358.3,4073,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,4074,0)
 ;;=333.94^^38^297^34
 ;;^UTILITY(U,$J,358.3,4074,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4074,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,4074,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,4074,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,4075,0)
 ;;=345.90^^38^297^36
 ;;^UTILITY(U,$J,358.3,4075,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4075,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,4075,1,5,0)
 ;;=5^Seizure Disorder
 ;;^UTILITY(U,$J,358.3,4075,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,4076,0)
 ;;=V12.54^^38^297^19
 ;;^UTILITY(U,$J,358.3,4076,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4076,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,4076,1,5,0)
 ;;=5^HX OF STROKE W/O RESIDUALS
 ;;^UTILITY(U,$J,358.3,4076,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,4077,0)
 ;;=305.01^^38^298^11
 ;;^UTILITY(U,$J,358.3,4077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4077,1,4,0)
 ;;=4^305.01
 ;;^UTILITY(U,$J,358.3,4077,1,5,0)
 ;;=5^Etoh Abuse-Continuous
 ;;^UTILITY(U,$J,358.3,4077,2)
 ;;=^268228
 ;;^UTILITY(U,$J,358.3,4078,0)
 ;;=305.02^^38^298^1
 ;;^UTILITY(U,$J,358.3,4078,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4078,1,4,0)
 ;;=4^305.02
 ;;^UTILITY(U,$J,358.3,4078,1,5,0)
 ;;=5^Alcohol Abuse-Episodic
 ;;^UTILITY(U,$J,358.3,4078,2)
 ;;=^268229
 ;;^UTILITY(U,$J,358.3,4079,0)
 ;;=305.03^^38^298^2
 ;;^UTILITY(U,$J,358.3,4079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4079,1,4,0)
 ;;=4^305.03
 ;;^UTILITY(U,$J,358.3,4079,1,5,0)
 ;;=5^Alcohol Abuse-In Remiss
 ;;^UTILITY(U,$J,358.3,4079,2)
 ;;=^268230
 ;;^UTILITY(U,$J,358.3,4080,0)
 ;;=303.90^^38^298^12
 ;;^UTILITY(U,$J,358.3,4080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4080,1,4,0)
 ;;=4^303.90
 ;;^UTILITY(U,$J,358.3,4080,1,5,0)
 ;;=5^Etoh Dependence
 ;;^UTILITY(U,$J,358.3,4080,2)
 ;;=^268187
 ;;^UTILITY(U,$J,358.3,4081,0)
 ;;=300.00^^38^298^3
 ;;^UTILITY(U,$J,358.3,4081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4081,1,4,0)
 ;;=4^300.00
 ;;^UTILITY(U,$J,358.3,4081,1,5,0)
 ;;=5^Anxiety
 ;;^UTILITY(U,$J,358.3,4081,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,4082,0)
 ;;=296.7^^38^298^4
 ;;^UTILITY(U,$J,358.3,4082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4082,1,4,0)
 ;;=4^296.7
 ;;^UTILITY(U,$J,358.3,4082,1,5,0)
 ;;=5^Bipolar Affective Disorder
 ;;^UTILITY(U,$J,358.3,4082,2)
 ;;=^14793
 ;;^UTILITY(U,$J,358.3,4083,0)
 ;;=304.20^^38^298^5
 ;;^UTILITY(U,$J,358.3,4083,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4083,1,4,0)
 ;;=4^304.20
 ;;^UTILITY(U,$J,358.3,4083,1,5,0)
 ;;=5^Cocaine Dependence
 ;;^UTILITY(U,$J,358.3,4083,2)
 ;;=^25599
 ;;^UTILITY(U,$J,358.3,4084,0)
 ;;=294.11^^38^298^7
 ;;^UTILITY(U,$J,358.3,4084,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4084,1,4,0)
 ;;=4^294.11
 ;;^UTILITY(U,$J,358.3,4084,1,5,0)
 ;;=5^Dementia W/Behav Disturb
 ;;^UTILITY(U,$J,358.3,4084,2)
 ;;=^321982
 ;;^UTILITY(U,$J,358.3,4085,0)
 ;;=294.10^^38^298^8
 ;;^UTILITY(U,$J,358.3,4085,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4085,1,4,0)
 ;;=4^294.10
 ;;^UTILITY(U,$J,358.3,4085,1,5,0)
 ;;=5^Dementia W/O Behav Disturb
 ;;^UTILITY(U,$J,358.3,4085,2)
 ;;=^321980
 ;;^UTILITY(U,$J,358.3,4086,0)
 ;;=311.^^38^298^9
 ;;^UTILITY(U,$J,358.3,4086,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4086,1,4,0)
 ;;=4^311.
 ;;^UTILITY(U,$J,358.3,4086,1,5,0)
 ;;=5^Depression
 ;;^UTILITY(U,$J,358.3,4086,2)
 ;;=^35603
 ;;^UTILITY(U,$J,358.3,4087,0)
 ;;=309.0^^38^298^10
 ;;^UTILITY(U,$J,358.3,4087,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4087,1,4,0)
 ;;=4^309.0
 ;;^UTILITY(U,$J,358.3,4087,1,5,0)
 ;;=5^Depressive Reaction, Brief
 ;;^UTILITY(U,$J,358.3,4087,2)
 ;;=^3308
 ;;^UTILITY(U,$J,358.3,4088,0)
 ;;=305.50^^38^298^13
 ;;^UTILITY(U,$J,358.3,4088,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4088,1,4,0)
 ;;=4^305.50
 ;;^UTILITY(U,$J,358.3,4088,1,5,0)
 ;;=5^IV Drug Use
 ;;^UTILITY(U,$J,358.3,4088,2)
 ;;=^85868
 ;;^UTILITY(U,$J,358.3,4089,0)
 ;;=302.72^^38^298^14
 ;;^UTILITY(U,$J,358.3,4089,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4089,1,4,0)
 ;;=4^302.72
 ;;^UTILITY(U,$J,358.3,4089,1,5,0)
 ;;=5^Inhibited Sex Excitement(Not Organic Impotence)
 ;;^UTILITY(U,$J,358.3,4089,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,4090,0)
 ;;=780.52^^38^298^15
 ;;^UTILITY(U,$J,358.3,4090,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4090,1,4,0)
 ;;=4^780.52
 ;;^UTILITY(U,$J,358.3,4090,1,5,0)
 ;;=5^Insomnia, Unspec
 ;;^UTILITY(U,$J,358.3,4090,2)
 ;;=^87662
 ;;^UTILITY(U,$J,358.3,4091,0)
 ;;=300.3^^38^298^16
 ;;^UTILITY(U,$J,358.3,4091,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4091,1,4,0)
 ;;=4^300.3
 ;;^UTILITY(U,$J,358.3,4091,1,5,0)
 ;;=5^Obsessive-Compulsive
 ;;^UTILITY(U,$J,358.3,4091,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,4092,0)
 ;;=304.00^^38^298^17
